Mellaril-S
Brand names,
Mellaril-S
Analogs
Mellaril-S
Brand Names Mixture
Mellaril-S
Chemical_Formula
C21H26N2S2
Mellaril-S
RX_link
http://www.rxlist.com/cgi/generic3/thioridazine.htm
Mellaril-S
fda sheet
Mellaril-S
msds (material safety sheet)
Mellaril-S
Synthesis Reference
Bourquin et al., Helv. Chim. Acta 41, 1072 (1958)
Mellaril-S
Molecular Weight
370.577 g/mol
Mellaril-S
Melting Point
73 oC
Mellaril-S
H2O Solubility
0.0336 mg/L
Mellaril-S
State
Solid
Mellaril-S
LogP
6.552
Mellaril-S
Dosage Forms
Suspension; Tablet
Mellaril-S
Indication
For the treatment of schizophrenia and generalized anxiety disorder.
Mellaril-S
Pharmacology
Thioridazine is a trifluoro-methyl phenothiazine derivative intended for the management of schizophrenia and other psychotic disorders. Thioridazine has not been shown effective in the management of behaviorial complications in patients with mental retardation.
Mellaril-S
Absorption
60%
Mellaril-S
side effects and Toxicity
LD50=956-1034 mg/kg (Orally in rats); Agitation, blurred vision, coma, confusion, constipation, difficulty breathing, dilated or constricted pupils, diminished flow of urine, dry mouth, dry skin, excessively high or low body temperature, extremely low blood pressure, fluid in the lungs, heart abnormalities, inability to urinate, intestinal blockage, nasal congestion, restlessness, sedation, seizures, shock
Mellaril-S
Patient Information
Mellaril-S
Organisms Affected
Humans and other mammals